Skip to content
investormap

Kurma Partners

Venture capital

RollingLast verified 10 Nov 2026

European healthcare and biotech venture capital firm that builds spin-offs with academic research institutions and invests in early-stage medical device and biopharma companies.

5 deals in the last 24 months, latest 6 Oct 2026. From its website and its deals in the news.

Key facts

Stages
Pre-seed, Seed, Series A, Series C+
Sectors
Biotech & pharma, Healthtech, Medtech
Typical round size
€45M (median of its recent deals, not a ticket)
Leads rounds
0% of recent deals with a known role
Eligible countries
Not stated
Provider based in
France
Timing
Rolling applications
Focus
healthcare and biotechnology; cutting-edge medicines or medical devices; severe diseases with high unmet medical need
How to apply
Apply route unknown

Recent deals

Deals in the last 24 months
CompanyRoundSectorsAmountRoleAnnounced
RougeTxSeries ABiotech & pharma, Healthtech€51.9Mparticipant6 Oct 2026
AdcytherixSeries ABiotech & pharma€105M–16 Oct 2025
Step Pharma · FranceSeries C+Biotech & pharma, Healthtech€38Mparticipant15 Oct 2025
DeepUll · SpainSeries C+Healthtech, Medtech, Biotech & pharma–participant29 Apr 2025
Coave TherapeuticsSeries ABiotech & pharma€32Mparticipant9 Jan 2025

Funds

Evidence

Short excerpts from the sources, in their original language, that back the facts above.

Status history

  • 6 Nov 2026: Rolling (first extraction)

Is something out of date?

Suggest an editTakes 10 seconds
What is wrong?

Please do not include names, email addresses or phone numbers of people.

Something else wrong? Report an error.

Work at Kurma Partners? Claim this profile to confirm what you invest in.